In this study, we not only confirmed the anti-tumor effect of DMY in a human CCA cell-engrafted nude mice model, but also showed that DMY inhibited EMT through targeting miR-455/ZEB1 axis, an important mechanism associated with tumor initiation and progression in various cancer types, in human CCA both in vitro and in vivo experiments. The gene discussed is ZEB1; the disease is cancer.